HTR2A and Prader-Willi syndrome: Studies suggest that 5-HT2A binding sites are higher in non-medicated PWS compared with HV, and antipsychotic consumption decreases the binding sites during the first 12 months of therapy, However, after the first year of use, 5-HT2A binding sites tend to increase again [85].